Post
Regeneron and Intellia expand partnership to develop CRISPR-based therapies
Regeneron Pharmaceuticals has entered an expanded research collaboration with Intellia Therapeutics to develop clustered, regularly interspaced, short palindromic repeats (CRISPR)-based …
FDA grants EUA for Novavax’s updated Covid-19 vaccine
The US Food and Drug Administration (FDA) has amended the emergency use authorisation of Novavax’s adjuvanted Covid-19 vaccine (NVX-CoV2601) to …
Lilly agrees to buy POINT Biopharma for $1.4bn
Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of radiopharmaceutical company POINT …
WHO’s SAGE recommends Takeda’s dengue vaccine
The World Health Organisation’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended Takeda’s QDENGA (dengue tetravalent vaccine [live, attenuated]) …
Nitric oxide by NOxy Health Products for Diabetic Foot Ulcers: Likelihood of Approval
Nitric oxide is under clinical development by NOxy Health Products and currently in Phase I for Diabetic Foot Ulcers. According …
FluoGuide imaging agent wins FDA orphan drug designation for glioma surgery
The US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to FluoGuide’s optical imaging agent, FG001. The FDA …
Regeneron and Intellia expand partnership to develop CRISPR-based therapies
Regeneron Pharmaceuticals has entered an expanded research collaboration with Intellia Therapeutics to develop clustered, regularly interspaced, short palindromic repeats (CRISPR)-based …
FDA grants EUA for Novavax’s updated Covid-19 vaccine
The US Food and Drug Administration (FDA) has amended the emergency use authorisation of Novavax’s adjuvanted Covid-19 vaccine (NVX-CoV2601) to …
Lilly agrees to buy POINT Biopharma for $1.4bn
Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of radiopharmaceutical company POINT …
WHO’s SAGE recommends Takeda’s dengue vaccine
The World Health Organisation’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended Takeda’s QDENGA (dengue tetravalent vaccine [live, attenuated]) …
Nitric oxide by NOxy Health Products for Diabetic Foot Ulcers: Likelihood of Approval
Nitric oxide is under clinical development by NOxy Health Products and currently in Phase I for Diabetic Foot Ulcers. According …
Super DC Vaccine by Shanghai Cell Therapy Group for Solid Tumor: Likelihood of Approval
Super DC Vaccine is under clinical development by Shanghai Cell Therapy Group and currently in Phase I for Solid Tumor. …
MC-232 by MC2 Therapeutics for Hidradenitis Suppurativa: Likelihood of Approval
MC-232 is under clinical development by MC2 Therapeutics and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase …
CD123-targeted CAR-NK by Chongqing Precision Biotech for Natural Killer Cell Lymphomas: Likelihood of Approval
CD123-targeted CAR-NK is under clinical development by Chongqing Precision Biotech and currently in Phase II for Natural Killer Cell Lymphomas. …
BGB-26808 by BeiGene for Solid Tumor: Likelihood of Approval
BGB-26808 is under clinical development by BeiGene and currently in Phase I for Solid Tumor. According to GlobalData, Phase I …